Quick Answer
Nutex Health Inc. reported Total Revenue of $875.26 million for the year ending 2025.
- Nutex Health Inc. showed an increase of +82.4% in Total Revenue from 2024 to 2025.
- This data is from Nutex Health Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $4.6 thousand | Q1 2018: $4.2 thousand | Q2 2018: $3.7 thousand | Q3 2018: $22.6 thousand | Q1 2019: $212.1 thousand | Q3 2019: $194.6 thousand | Q1 2020: $465.6 thousand | Q2 2020: $378.6 thousand | Q3 2020: $350.0 thousand | Q1 2021: $2.01 million | Q2 2021: $62.81 million | Q3 2021: $117.97 million | Q1 2022: $79.13 million | Q2 2022: $58.05 million | Q3 2022: $28.40 million | Q4 2022: $53.72 million | Q1 2023: $56.33 million | Q2 2023: $58.92 million | Q3 2023: $62.72 million | Q4 2023: $69.67 million | Q1 2024: $67.45 million | Q2 2024: $76.08 million | Q3 2024: $78.80 million | Q4 2024: $257.62 million | Q1 2025: $211.79 million | Q2 2025: $243.99 million | Q3 2025: $267.80 million.
- Over the full 8 years of available data (2018 to 2025), Nutex Health Inc.'s Total Revenue has grown by 63,927.8%.
- Historical annual values: Fiscal year 2025: $875.26 million | Fiscal year 2024: $479.95 million | Fiscal year 2023: $247.65 million | Fiscal year 2022: $219.29 million | Fiscal year 2021: $331.53 million | Fiscal year 2020: $274.03 million | Fiscal year 2019: $1.37 million | Fiscal year 2018: $1.37 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: